Drawing for ADHANSIA

USPTO serial 87440283

ADHANSIA

Reviewed by CopyMark Law Group

Reg. 6208234Status 700Renewal
Filing date
Status date
Registration date
Dec 1, 2020
Examiner
SPILS, CAROL A
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ADHANSIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Fara S. Sunderji

Fara S. Sunderji Dorsey & Whitney LLP51 West 52nd StreetNew York, NY 10019-6119UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders, mood disorders, oppositional defiance disorder, conduct disorder, learning disabilities, autism spectrum disorder, tic disorders, binge eating and obsessive eating disorders, anxiety disorders, substance abuse disorders, depression, psychosisACTIVE—
044Providing health information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, via a website, the Internet or other global communication networks; providing health information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the treatment of diseases and disorders of the central nervous systemACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 19, 2026ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 1, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Dec 1, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 27, 2020DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Oct 9, 2020IUCNNOTICE OF ALLOWANCE CANCELLED—
Oct 9, 2020D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Oct 8, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 8, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 8, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 28, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 3, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 3, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 12, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 29, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 25, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 25, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 25, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 22, 2020ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Aug 8, 2019GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Aug 8, 2019GNSIINQUIRY TO SUSPENSION E-MAILED—
Aug 8, 2019CNSISUSPENSION INQUIRY WRITTEN—
Feb 20, 2019ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Feb 13, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 13, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 8, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 8, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Feb 8, 2019CNSLSUSPENSION LETTER WRITTEN—
Jan 17, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 17, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 17, 2019CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 16, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jul 18, 2018GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jul 18, 2018GNSIINQUIRY TO SUSPENSION E-MAILED—
Jul 18, 2018CNSISUSPENSION INQUIRY WRITTEN—
Jul 13, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 13, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 13, 2018ALIEASSIGNED TO LIE—
Jun 29, 2018EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Feb 3, 2018GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 3, 2018GNSLLETTER OF SUSPENSION E-MAILED—
Feb 3, 2018CNSLSUSPENSION LETTER WRITTEN—
Jan 30, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 29, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 29, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 5, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 5, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 5, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 4, 2017DOCKASSIGNED TO EXAMINER—
May 11, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 11, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance